What were the pros and cons of a transplanted human pancreatic islets product in patients with type 1 diabetes and impaired awareness of hypoglycemia?
Veronica Hackethal, MD
Researchers investigated changes in biomarker levels of obese patients with type 2 diabetes taking dapagliflozin.
What role, if any, does vitamin D play in the development of diabetes or diabetic complications?
Investigators examined cardiovascular risk with the new basal insulin peglispro compared to insulin glargine or NPH in diabetic patients.
Investigators compared initial therapy with canagliflozin plus metformin to metformin monotherapy in drug naïve type 2 diabetes patients.
As adjunctive therapy with insulin in poorly controlled type 2 diabetes, which drugs proved more effective – SGLT2 inhibitors or DPP-4 inhibitors?
Changes in the composition of the gut microbiome may contribute to the development of anti-islet autoimmunity, according to the BABYDIET study.
Several trials are due to be completed this year, bringing the hope that at least one artificial pancreas system will come to market in 2017.
To address conflicting reports about the cardiovascular safety of DPP-4 inhibitors, researchers performed a large retrospective cohort study.
Even though canagliflozin improves adiposity and glycemic control, a small study may have uncovered a surprising drug-related outcome.